data_1uao_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1uao _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.593 ' HB2' ' CZ3' ' A' ' 9' ' ' TRP . 74.8 t80 -84.83 97.91 10.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -1.134 . . . . 0.0 109.577 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.402 ' OD2' ' HB3' ' A' ' 5' ' ' GLU . 38.5 t70 -71.7 115.19 35.24 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.321 -0.862 . . . . 0.0 109.051 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 34.6 Cg_endo -75.96 -12.83 19.64 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.258 1.972 . . . . 0.0 110.214 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.414 ' OE1' HG21 ' A' ' 6' ' ' THR . 0.7 OUTLIER -60.28 -39.37 86.6 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.263 -0.898 . . . . 0.0 108.904 179.536 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.414 HG21 ' OE1' ' A' ' 5' ' ' GLU . 17.1 p -107.05 -22.46 12.65 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.377 -0.827 . . . . 0.0 109.002 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.429 ' O ' HG23 ' A' ' 8' ' ' THR . . . 90.81 34.07 7.98 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 7' ' ' GLY . 0.0 OUTLIER -160.7 165.35 30.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.066 -1.255 . . . . 0.0 109.935 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.593 ' CZ3' ' HB2' ' A' ' 2' ' ' TYR . 4.9 m95 -69.16 107.11 3.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.382 -0.824 . . . . 0.0 109.375 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 CA-C-O 117.98 -1.455 . . . . 0.0 109.612 -179.929 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.608 ' HB2' ' CZ3' ' A' ' 9' ' ' TRP . 90.1 t80 -94.49 110.13 21.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -1.146 . . . . 0.0 109.459 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.444 ' OD1' ' HB2' ' A' ' 5' ' ' GLU . 12.9 t70 -77.8 114.0 37.53 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.161 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 36.1 Cg_endo -78.56 -27.67 4.92 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.291 1.994 . . . . 0.0 110.315 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.444 ' HB2' ' OD1' ' A' ' 3' ' ' ASP . 0.2 OUTLIER -51.49 -43.43 62.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.327 -0.858 . . . . 0.0 109.395 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 44.4 p -99.47 -19.51 16.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -0.925 . . . . 0.0 109.483 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.458 ' O ' ' OH ' ' A' ' 2' ' ' TYR . . . 90.98 24.39 27.46 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.444 ' HA ' ' CE1' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -160.35 172.18 17.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -1.139 . . . . 0.0 109.631 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.608 ' CZ3' ' HB2' ' A' ' 2' ' ' TYR . 5.1 m95 -68.88 107.78 3.21 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.382 -0.824 . . . . 0.0 109.381 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.927 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.593 ' HB2' ' CZ3' ' A' ' 9' ' ' TRP . 85.1 t80 -83.29 109.56 17.35 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.284 -1.127 . . . . 0.0 109.489 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -74.42 114.3 32.39 Favored Pre-proline 0 N--CA 1.488 1.43 0 O-C-N 121.212 -0.93 . . . . 0.0 109.055 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 34.6 Cg_endo -76.23 -29.53 6.29 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.234 1.956 . . . . 0.0 110.229 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -62.18 -35.71 79.68 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.193 -0.942 . . . . 0.0 108.929 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.462 ' O ' HG22 ' A' ' 6' ' ' THR . 53.3 m -94.97 -16.7 22.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.267 -0.895 . . . . 0.0 109.144 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.469 ' O ' ' OH ' ' A' ' 2' ' ' TYR . . . 76.79 18.76 78.57 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.77 171.81 18.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.294 -1.121 . . . . 0.0 109.593 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.593 ' CZ3' ' HB2' ' A' ' 2' ' ' TYR . 9.4 m95 -68.79 112.22 5.37 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.348 -0.845 . . . . 0.0 109.533 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 CA-C-O 118.0 -1.445 . . . . 0.0 109.509 -179.98 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.588 ' HB2' ' CZ3' ' A' ' 9' ' ' TRP . 84.6 t80 -88.73 103.28 15.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.237 -1.155 . . . . 0.0 109.762 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -73.67 116.6 53.27 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.217 -0.927 . . . . 0.0 108.689 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -74.23 -27.43 11.6 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.175 1.917 . . . . 0.0 110.321 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.435 ' O ' ' HG3' ' A' ' 5' ' ' GLU . 1.1 tp10 -67.84 -24.2 65.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 108.56 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.19 -18.89 13.99 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.52 -0.737 . . . . 0.0 109.074 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.32 24.61 76.08 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.34 164.51 32.43 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.046 -1.267 . . . . 0.0 109.988 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.588 ' CZ3' ' HB2' ' A' ' 2' ' ' TYR . 6.6 m95 -69.03 -167.59 0.11 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.433 -0.792 . . . . 0.0 109.207 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 CA-C-O 118.02 -1.433 . . . . 0.0 109.629 179.911 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.59 ' HA ' ' CE3' ' A' ' 9' ' ' TRP . 83.2 t80 -73.25 135.69 44.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -1.105 . . . . 0.0 109.259 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -95.81 109.52 46.71 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.335 -0.853 . . . . 0.0 109.279 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 35.4 Cg_endo -77.14 -28.32 5.97 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.33 2.02 . . . . 0.0 110.155 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -51.97 -53.53 40.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.262 -0.899 . . . . 0.0 108.979 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.6 t -99.99 -7.01 25.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.38 -0.825 . . . . 0.0 109.315 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.439 ' C ' ' OH ' ' A' ' 2' ' ' TYR . . . 71.24 33.31 64.82 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.53 156.16 25.39 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.125 -1.221 . . . . 0.0 110.102 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.59 ' CE3' ' HA ' ' A' ' 2' ' ' TYR . 11.0 m95 -68.95 -35.42 76.75 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.565 -0.709 . . . . 0.0 109.759 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 CA-C-O 118.03 -1.428 . . . . 0.0 109.735 -179.77 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.602 ' HB2' ' CZ3' ' A' ' 9' ' ' TRP . 89.8 t80 -71.71 166.84 21.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -1.091 . . . . 0.0 109.524 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.492 ' N ' ' CG ' ' A' ' 2' ' ' TYR . 0.6 OUTLIER -127.15 112.53 21.61 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.317 -0.864 . . . . 0.0 109.01 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.99 -37.48 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.203 1.935 . . . . 0.0 110.73 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -61.65 -47.77 83.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.108 -0.995 . . . . 0.0 108.9 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 57.4 m -80.78 -62.69 1.6 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.359 -0.838 . . . . 0.0 108.934 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.415 ' C ' ' OH ' ' A' ' 2' ' ' TYR . . . 127.2 22.95 1.46 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.418 ' O ' ' HB2' ' A' ' 3' ' ' ASP . 0.6 OUTLIER -160.57 172.24 17.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.043 -1.269 . . . . 0.0 110.02 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.602 ' CZ3' ' HB2' ' A' ' 2' ' ' TYR . 25.0 m95 -68.76 -43.02 76.68 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.487 -0.758 . . . . 0.0 109.602 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 CA-C-O 118.069 -1.406 . . . . 0.0 109.586 -179.94 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.574 ' HB2' ' CZ3' ' A' ' 9' ' ' TRP . 17.5 t80 -115.43 105.88 13.33 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.188 -1.184 . . . . 0.0 109.562 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -77.59 114.45 41.06 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.251 -0.906 . . . . 0.0 109.156 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 34.7 Cg_endo -76.8 -22.9 11.4 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.263 1.976 . . . . 0.0 110.32 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -54.03 -25.46 21.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -0.888 . . . . 0.0 109.148 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.4 p -121.01 -53.23 2.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.368 -0.832 . . . . 0.0 109.266 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.91 62.85 0.52 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.49 147.56 27.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.202 -1.175 . . . . 0.0 109.868 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.574 ' CZ3' ' HB2' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -77.31 -18.81 57.19 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.84 -179.369 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 CA-C-O 117.967 -1.463 . . . . 0.0 109.538 -179.926 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.514 ' HB2' ' CH2' ' A' ' 9' ' ' TRP . 72.5 t80 -70.62 117.06 11.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.17 -1.194 . . . . 0.0 109.64 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -81.13 114.54 49.76 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.196 -0.94 . . . . 0.0 109.117 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 35.1 Cg_endo -77.82 -33.99 1.99 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.413 2.075 . . . . 0.0 110.497 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -68.3 -55.05 13.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.194 -0.941 . . . . 0.0 109.402 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 55.9 m -80.28 -21.75 42.34 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.322 -0.861 . . . . 0.0 109.166 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 62.93 59.13 9.56 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.47 149.73 35.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.167 -1.196 . . . . 0.0 109.668 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.58 ' CE3' ' HA ' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -87.59 38.27 0.82 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.545 -0.722 . . . . 0.0 109.907 -179.389 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.354 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.62 -179.912 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.476 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 18.5 t80 -87.78 109.58 19.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.211 -1.17 . . . . 0.0 109.515 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -73.32 114.04 27.78 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.297 -0.877 . . . . 0.0 109.254 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 34.8 Cg_endo -77.55 -26.81 6.8 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.318 2.012 . . . . 0.0 110.55 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -53.43 -56.88 13.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.069 -1.019 . . . . 0.0 109.349 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.0 p -91.5 -38.47 12.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.093 -1.004 . . . . 0.0 109.376 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.56 67.59 1.11 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.58 152.15 33.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -1.124 . . . . 0.0 109.804 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.583 ' CE3' ' HA ' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -83.06 -56.25 3.9 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.59 -0.693 . . . . 0.0 109.892 -179.259 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 CA-C-O 117.987 -1.451 . . . . 0.0 109.566 -179.951 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.46 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 84.5 t80 -65.25 120.0 11.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.239 -1.154 . . . . 0.0 109.58 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.29 114.0 51.97 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.238 -0.914 . . . . 0.0 109.264 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 35.2 Cg_endo -77.45 -12.75 16.9 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.337 2.025 . . . . 0.0 110.418 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.19 -52.76 6.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.253 -0.904 . . . . 0.0 109.386 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 63.9 p -83.8 -46.15 12.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 109.395 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.19 62.38 1.29 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.2 m -158.32 153.97 26.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -1.166 . . . . 0.0 109.718 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.599 ' CE3' ' HA ' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -93.84 89.16 6.02 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.567 -0.708 . . . . 0.0 109.737 -179.545 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.948 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.438 ' C ' ' CD1' ' A' ' 2' ' ' TYR . 11.5 t80 -72.02 103.55 3.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -1.17 . . . . 0.0 109.65 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.401 ' OD1' ' HD2' ' A' ' 4' ' ' PRO . 45.3 t0 -84.29 117.85 69.72 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.348 -0.845 . . . . 0.0 109.173 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.401 ' HD2' ' OD1' ' A' ' 3' ' ' ASP . 34.3 Cg_endo -76.96 -16.42 16.02 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.273 1.982 . . . . 0.0 110.227 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.04 -16.31 62.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 108.926 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.5 m -116.47 -54.27 2.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.458 -0.776 . . . . 0.0 109.267 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.63 53.0 1.08 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.25 152.83 22.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.215 -1.167 . . . . 0.0 109.861 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.579 ' CE3' ' HA ' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -84.72 -72.89 0.45 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.604 -0.685 . . . . 0.0 109.759 -179.462 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 CA-C-O 117.984 -1.453 . . . . 0.0 109.533 179.903 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.521 ' HB2' ' CH2' ' A' ' 9' ' ' TRP . 60.2 t80 -87.13 127.18 35.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -1.152 . . . . 0.0 109.554 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -89.34 113.96 58.5 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.241 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 35.3 Cg_endo -77.54 -9.88 17.3 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.322 2.014 . . . . 0.0 110.41 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -81.26 -57.31 3.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 109.355 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.6 m -85.44 -45.24 12.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.285 -0.884 . . . . 0.0 109.468 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.98 71.55 1.07 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.5 m -154.12 152.4 30.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -1.148 . . . . 0.0 109.794 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.596 ' CE3' ' HA ' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -93.27 57.7 2.72 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.824 -179.472 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 9' ' ' TRP . . . . . . . . 0 N--CA 1.49 2.263 0 CA-C-O 118.036 -1.424 . . . . 0.0 109.596 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.531 ' HB2' ' CH2' ' A' ' 9' ' ' TRP . 32.5 t80 -106.27 111.2 23.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -1.139 . . . . 0.0 109.537 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -94.38 118.45 67.01 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.296 -0.877 . . . . 0.0 109.276 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.06 -23.08 9.46 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.293 1.996 . . . . 0.0 110.337 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -53.31 -20.97 4.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 109.461 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -128.99 -47.28 1.23 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.286 -0.884 . . . . 0.0 109.267 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.86 64.97 0.82 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.94 150.77 33.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.108 -1.23 . . . . 0.0 109.858 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.598 ' CE3' ' HA ' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -90.88 42.8 1.12 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.563 -0.711 . . . . 0.0 109.927 -179.29 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 CA-C-O 117.955 -1.469 . . . . 0.0 109.552 179.945 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.589 ' HB2' ' CZ3' ' A' ' 9' ' ' TRP . 32.2 t80 -99.75 119.04 37.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -1.155 . . . . 0.0 109.48 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.74 117.83 67.72 Favored Pre-proline 0 N--CA 1.487 1.425 0 O-C-N 121.218 -0.926 . . . . 0.0 109.334 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -76.6 -22.18 12.33 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.363 2.042 . . . . 0.0 110.253 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -66.61 -43.86 83.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.349 -0.845 . . . . 0.0 109.112 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.7 m -102.47 -58.06 1.94 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.332 -0.855 . . . . 0.0 109.221 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.0 80.04 0.82 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.86 149.29 27.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -1.175 . . . . 0.0 109.86 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.589 ' CZ3' ' HB2' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -88.57 8.55 27.71 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.708 -0.62 . . . . 0.0 109.94 -179.395 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 CA-C-O 117.952 -1.471 . . . . 0.0 109.572 -179.978 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.595 ' HB2' ' CZ3' ' A' ' 9' ' ' TRP . 61.5 t80 -93.52 110.12 21.71 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.221 -1.164 . . . . 0.0 109.486 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -73.39 115.04 37.21 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.208 -0.932 . . . . 0.0 109.032 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 34.4 Cg_endo -75.71 -10.23 20.02 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.225 1.95 . . . . 0.0 110.163 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -81.02 -40.58 24.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.296 -0.877 . . . . 0.0 108.751 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.4 m -111.81 -52.58 2.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.395 -0.815 . . . . 0.0 108.827 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.449 ' HA2' ' CZ ' ' A' ' 2' ' ' TYR . . . 104.73 84.82 1.8 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.26 134.92 7.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.262 -1.14 . . . . 0.0 109.987 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.595 ' CZ3' ' HB2' ' A' ' 2' ' ' TYR . 2.4 m95 -78.96 88.77 4.74 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.607 -0.683 . . . . 0.0 109.608 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 CA-C-O 117.925 -1.486 . . . . 0.0 109.502 -179.897 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.439 ' CZ ' ' HA2' ' A' ' 7' ' ' GLY . 66.2 t80 -78.76 138.6 38.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -1.134 . . . . 0.0 109.486 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -103.54 117.48 59.88 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.255 -0.903 . . . . 0.0 109.142 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -75.97 -9.26 19.37 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.317 2.012 . . . . 0.0 110.424 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -84.36 -49.78 8.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.228 -0.92 . . . . 0.0 109.106 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.437 HG23 ' OG1' ' A' ' 8' ' ' THR . 24.2 m -100.04 -48.82 4.51 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.28 -0.888 . . . . 0.0 109.19 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.439 ' HA2' ' CZ ' ' A' ' 2' ' ' TYR . . . 91.68 61.08 1.24 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.437 ' OG1' HG23 ' A' ' 6' ' ' THR . 0.2 OUTLIER -137.63 149.87 46.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.162 -1.199 . . . . 0.0 109.732 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.578 ' CE3' ' HA ' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -100.12 11.35 39.56 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.731 -179.505 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 CA-C-O 118.022 -1.432 . . . . 0.0 109.539 179.989 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -83.24 133.79 34.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -1.122 . . . . 0.0 109.437 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -98.96 116.11 65.43 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.311 -0.868 . . . . 0.0 109.287 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.66 -4.27 14.78 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.257 1.971 . . . . 0.0 110.102 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.424 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 7.0 tp10 -87.29 -49.37 7.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.332 -0.855 . . . . 0.0 109.092 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.4 p -107.56 -41.36 5.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.34 -0.85 . . . . 0.0 109.236 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.44 79.92 1.48 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.24 149.88 29.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.176 -1.191 . . . . 0.0 109.81 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.595 ' CE3' ' HA ' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -98.62 -25.79 14.6 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.501 -0.75 . . . . 0.0 109.963 -179.479 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 CA-C-O 117.975 -1.458 . . . . 0.0 109.568 180.0 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.518 ' CZ ' ' HA2' ' A' ' 7' ' ' GLY . 63.0 t80 -87.54 153.19 21.6 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.31 -1.112 . . . . 0.0 109.239 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -122.7 117.07 28.95 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.181 -0.95 . . . . 0.0 109.315 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.66 -9.25 17.17 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.282 1.988 . . . . 0.0 110.196 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -76.36 -38.91 55.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.368 -0.832 . . . . 0.0 109.137 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.9 m -117.07 -55.34 2.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.27 -0.894 . . . . 0.0 108.982 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.518 ' HA2' ' CZ ' ' A' ' 2' ' ' TYR . . . 109.9 85.17 1.61 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.1 m -156.8 150.75 24.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -1.155 . . . . 0.0 109.83 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.59 ' CE3' ' HA ' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -101.87 79.66 1.93 Allowed 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.002 -179.563 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.858 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.597 ' HB2' ' CZ3' ' A' ' 9' ' ' TRP . 74.8 t80 -84.83 97.91 10.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -1.134 . . . . 0.0 109.577 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.426 ' OD2' ' HB3' ' A' ' 5' ' ' GLU . 38.5 t70 -71.7 115.19 35.24 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.321 -0.862 . . . . 0.0 109.051 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 34.6 Cg_endo -75.96 -12.83 19.64 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.258 1.972 . . . . 0.0 110.214 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.426 ' HB3' ' OD2' ' A' ' 3' ' ' ASP . 0.7 OUTLIER -60.28 -39.37 86.6 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.263 -0.898 . . . . 0.0 108.904 179.536 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.1 p -107.05 -22.46 12.65 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.377 -0.827 . . . . 0.0 109.002 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.81 34.07 7.98 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.7 165.35 30.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.066 -1.255 . . . . 0.0 109.935 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.597 ' CZ3' ' HB2' ' A' ' 2' ' ' TYR . 4.9 m95 -69.16 107.11 3.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.382 -0.824 . . . . 0.0 109.375 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 CA-C-O 117.98 -1.455 . . . . 0.0 109.612 -179.929 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.607 ' HB2' ' CZ3' ' A' ' 9' ' ' TRP . 90.1 t80 -94.49 110.13 21.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -1.146 . . . . 0.0 109.459 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.456 ' OD1' ' HB2' ' A' ' 5' ' ' GLU . 12.9 t70 -77.8 114.0 37.53 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.161 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 36.1 Cg_endo -78.56 -27.67 4.92 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.291 1.994 . . . . 0.0 110.315 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.456 ' HB2' ' OD1' ' A' ' 3' ' ' ASP . 0.2 OUTLIER -51.49 -43.43 62.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.327 -0.858 . . . . 0.0 109.395 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 44.4 p -99.47 -19.51 16.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -0.925 . . . . 0.0 109.483 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.458 ' O ' ' OH ' ' A' ' 2' ' ' TYR . . . 90.98 24.39 27.46 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.453 ' HA ' ' CE1' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -160.35 172.18 17.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -1.139 . . . . 0.0 109.631 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.607 ' CZ3' ' HB2' ' A' ' 2' ' ' TYR . 5.1 m95 -68.88 107.78 3.21 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.382 -0.824 . . . . 0.0 109.381 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.927 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.594 ' HB2' ' CZ3' ' A' ' 9' ' ' TRP . 85.1 t80 -83.29 109.56 17.35 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.284 -1.127 . . . . 0.0 109.489 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -74.42 114.3 32.39 Favored Pre-proline 0 N--CA 1.488 1.43 0 O-C-N 121.212 -0.93 . . . . 0.0 109.055 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 34.6 Cg_endo -76.23 -29.53 6.29 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.234 1.956 . . . . 0.0 110.229 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -62.18 -35.71 79.68 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.193 -0.942 . . . . 0.0 108.929 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 53.3 m -94.97 -16.7 22.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.267 -0.895 . . . . 0.0 109.144 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.469 ' O ' ' OH ' ' A' ' 2' ' ' TYR . . . 76.79 18.76 78.57 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.406 ' HA ' ' CE1' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -160.77 171.81 18.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.294 -1.121 . . . . 0.0 109.593 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.594 ' CZ3' ' HB2' ' A' ' 2' ' ' TYR . 9.4 m95 -68.79 112.22 5.37 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.348 -0.845 . . . . 0.0 109.533 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 CA-C-O 118.0 -1.445 . . . . 0.0 109.509 -179.98 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.593 ' HB2' ' CZ3' ' A' ' 9' ' ' TRP . 84.6 t80 -88.73 103.28 15.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.237 -1.155 . . . . 0.0 109.762 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -73.67 116.6 53.27 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.217 -0.927 . . . . 0.0 108.689 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -74.23 -27.43 11.6 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.175 1.917 . . . . 0.0 110.321 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.446 ' O ' ' HG3' ' A' ' 5' ' ' GLU . 1.1 tp10 -67.84 -24.2 65.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 108.56 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.19 -18.89 13.99 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.52 -0.737 . . . . 0.0 109.074 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.32 24.61 76.08 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.34 164.51 32.43 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.046 -1.267 . . . . 0.0 109.988 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.593 ' CZ3' ' HB2' ' A' ' 2' ' ' TYR . 6.6 m95 -69.03 -167.59 0.11 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.433 -0.792 . . . . 0.0 109.207 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 CA-C-O 118.02 -1.433 . . . . 0.0 109.629 179.911 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.597 ' HA ' ' CE3' ' A' ' 9' ' ' TRP . 83.2 t80 -73.25 135.69 44.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -1.105 . . . . 0.0 109.259 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -95.81 109.52 46.71 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.335 -0.853 . . . . 0.0 109.279 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 35.4 Cg_endo -77.14 -28.32 5.97 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.33 2.02 . . . . 0.0 110.155 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -51.97 -53.53 40.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.262 -0.899 . . . . 0.0 108.979 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.6 t -99.99 -7.01 25.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.38 -0.825 . . . . 0.0 109.315 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.439 ' C ' ' OH ' ' A' ' 2' ' ' TYR . . . 71.24 33.31 64.82 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.53 156.16 25.39 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.125 -1.221 . . . . 0.0 110.102 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.597 ' CE3' ' HA ' ' A' ' 2' ' ' TYR . 11.0 m95 -68.95 -35.42 76.75 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.565 -0.709 . . . . 0.0 109.759 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 CA-C-O 118.03 -1.428 . . . . 0.0 109.735 -179.77 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.604 ' HB2' ' CZ3' ' A' ' 9' ' ' TRP . 89.8 t80 -71.71 166.84 21.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -1.091 . . . . 0.0 109.524 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.492 ' N ' ' CG ' ' A' ' 2' ' ' TYR . 0.6 OUTLIER -127.15 112.53 21.61 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.317 -0.864 . . . . 0.0 109.01 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.99 -37.48 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.203 1.935 . . . . 0.0 110.73 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -61.65 -47.77 83.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.108 -0.995 . . . . 0.0 108.9 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 57.4 m -80.78 -62.69 1.6 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.359 -0.838 . . . . 0.0 108.934 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.415 ' C ' ' OH ' ' A' ' 2' ' ' TYR . . . 127.2 22.95 1.46 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.432 ' O ' ' HB2' ' A' ' 3' ' ' ASP . 0.6 OUTLIER -160.57 172.24 17.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.043 -1.269 . . . . 0.0 110.02 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.604 ' CZ3' ' HB2' ' A' ' 2' ' ' TYR . 25.0 m95 -68.76 -43.02 76.68 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.487 -0.758 . . . . 0.0 109.602 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 CA-C-O 118.069 -1.406 . . . . 0.0 109.586 -179.94 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.577 ' HB2' ' CZ3' ' A' ' 9' ' ' TRP . 17.5 t80 -115.43 105.88 13.33 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.188 -1.184 . . . . 0.0 109.562 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -77.59 114.45 41.06 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.251 -0.906 . . . . 0.0 109.156 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 34.7 Cg_endo -76.8 -22.9 11.4 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.263 1.976 . . . . 0.0 110.32 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -54.03 -25.46 21.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -0.888 . . . . 0.0 109.148 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.4 p -121.01 -53.23 2.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.368 -0.832 . . . . 0.0 109.266 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.91 62.85 0.52 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.49 147.56 27.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.202 -1.175 . . . . 0.0 109.868 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.588 ' CE3' ' HA ' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -77.31 -18.81 57.19 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.84 -179.369 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 CA-C-O 117.967 -1.463 . . . . 0.0 109.538 -179.926 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.52 ' HB2' ' CH2' ' A' ' 9' ' ' TRP . 72.5 t80 -70.62 117.06 11.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.17 -1.194 . . . . 0.0 109.64 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -81.13 114.54 49.76 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.196 -0.94 . . . . 0.0 109.117 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 35.1 Cg_endo -77.82 -33.99 1.99 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.413 2.075 . . . . 0.0 110.497 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -68.3 -55.05 13.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.194 -0.941 . . . . 0.0 109.402 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.441 HG22 ' OG1' ' A' ' 8' ' ' THR . 55.9 m -80.28 -21.75 42.34 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.322 -0.861 . . . . 0.0 109.166 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 62.93 59.13 9.56 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.441 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -145.47 149.73 35.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.167 -1.196 . . . . 0.0 109.668 179.88 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.602 ' CE3' ' HA ' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -87.59 38.27 0.82 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.545 -0.722 . . . . 0.0 109.907 -179.389 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.354 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.62 -179.912 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.471 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 18.5 t80 -87.78 109.58 19.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.211 -1.17 . . . . 0.0 109.515 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -73.32 114.04 27.78 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.297 -0.877 . . . . 0.0 109.254 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 34.8 Cg_endo -77.55 -26.81 6.8 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.318 2.012 . . . . 0.0 110.55 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -53.43 -56.88 13.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.069 -1.019 . . . . 0.0 109.349 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.0 p -91.5 -38.47 12.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.093 -1.004 . . . . 0.0 109.376 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.56 67.59 1.11 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.58 152.15 33.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -1.124 . . . . 0.0 109.804 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.609 ' CE3' ' HA ' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -83.06 -56.25 3.9 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.59 -0.693 . . . . 0.0 109.892 -179.259 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 CA-C-O 117.987 -1.451 . . . . 0.0 109.566 -179.951 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.465 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 84.5 t80 -65.25 120.0 11.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.239 -1.154 . . . . 0.0 109.58 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.29 114.0 51.97 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.238 -0.914 . . . . 0.0 109.264 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 35.2 Cg_endo -77.45 -12.75 16.9 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.337 2.025 . . . . 0.0 110.418 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.19 -52.76 6.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.253 -0.904 . . . . 0.0 109.386 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 63.9 p -83.8 -46.15 12.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 109.395 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.19 62.38 1.29 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.2 m -158.32 153.97 26.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -1.166 . . . . 0.0 109.718 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.621 ' CE3' ' HA ' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -93.84 89.16 6.02 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.567 -0.708 . . . . 0.0 109.737 -179.545 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.948 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.444 ' HB2' ' CH2' ' A' ' 9' ' ' TRP . 11.5 t80 -72.02 103.55 3.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -1.17 . . . . 0.0 109.65 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.403 ' OD1' ' HD2' ' A' ' 4' ' ' PRO . 45.3 t0 -84.29 117.85 69.72 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.348 -0.845 . . . . 0.0 109.173 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.403 ' HD2' ' OD1' ' A' ' 3' ' ' ASP . 34.3 Cg_endo -76.96 -16.42 16.02 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.273 1.982 . . . . 0.0 110.227 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.04 -16.31 62.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 108.926 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.5 m -116.47 -54.27 2.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.458 -0.776 . . . . 0.0 109.267 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.63 53.0 1.08 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.25 152.83 22.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.215 -1.167 . . . . 0.0 109.861 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.597 ' CE3' ' HA ' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -84.72 -72.89 0.45 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.604 -0.685 . . . . 0.0 109.759 -179.462 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 CA-C-O 117.984 -1.453 . . . . 0.0 109.533 179.903 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.53 ' HB2' ' CH2' ' A' ' 9' ' ' TRP . 60.2 t80 -87.13 127.18 35.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -1.152 . . . . 0.0 109.554 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -89.34 113.96 58.5 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.241 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 35.3 Cg_endo -77.54 -9.88 17.3 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.322 2.014 . . . . 0.0 110.41 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -81.26 -57.31 3.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 109.355 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.6 m -85.44 -45.24 12.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.285 -0.884 . . . . 0.0 109.468 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.98 71.55 1.07 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.5 m -154.12 152.4 30.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -1.148 . . . . 0.0 109.794 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.617 ' CE3' ' HA ' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -93.27 57.7 2.72 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.824 -179.472 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 9' ' ' TRP . . . . . . . . 0 N--CA 1.49 2.263 0 CA-C-O 118.036 -1.424 . . . . 0.0 109.596 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.537 ' HB2' ' CH2' ' A' ' 9' ' ' TRP . 32.5 t80 -106.27 111.2 23.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -1.139 . . . . 0.0 109.537 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -94.38 118.45 67.01 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.296 -0.877 . . . . 0.0 109.276 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.06 -23.08 9.46 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.293 1.996 . . . . 0.0 110.337 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -53.31 -20.97 4.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 109.461 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -128.99 -47.28 1.23 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.286 -0.884 . . . . 0.0 109.267 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.86 64.97 0.82 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.94 150.77 33.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.108 -1.23 . . . . 0.0 109.858 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.618 ' CE3' ' HA ' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -90.88 42.8 1.12 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.563 -0.711 . . . . 0.0 109.927 -179.29 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 CA-C-O 117.955 -1.469 . . . . 0.0 109.552 179.945 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.603 ' HB2' ' CZ3' ' A' ' 9' ' ' TRP . 32.2 t80 -99.75 119.04 37.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -1.155 . . . . 0.0 109.48 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.74 117.83 67.72 Favored Pre-proline 0 N--CA 1.487 1.425 0 O-C-N 121.218 -0.926 . . . . 0.0 109.334 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -76.6 -22.18 12.33 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.363 2.042 . . . . 0.0 110.253 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -66.61 -43.86 83.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.349 -0.845 . . . . 0.0 109.112 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.7 m -102.47 -58.06 1.94 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.332 -0.855 . . . . 0.0 109.221 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.0 80.04 0.82 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.86 149.29 27.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -1.175 . . . . 0.0 109.86 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.603 ' CZ3' ' HB2' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -88.57 8.55 27.71 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.708 -0.62 . . . . 0.0 109.94 -179.395 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 CA-C-O 117.952 -1.471 . . . . 0.0 109.572 -179.978 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.603 ' HB2' ' CZ3' ' A' ' 9' ' ' TRP . 61.5 t80 -93.52 110.12 21.71 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.221 -1.164 . . . . 0.0 109.486 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -73.39 115.04 37.21 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.208 -0.932 . . . . 0.0 109.032 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 34.4 Cg_endo -75.71 -10.23 20.02 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.225 1.95 . . . . 0.0 110.163 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -81.02 -40.58 24.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.296 -0.877 . . . . 0.0 108.751 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.4 m -111.81 -52.58 2.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.395 -0.815 . . . . 0.0 108.827 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.468 ' HA2' ' CZ ' ' A' ' 2' ' ' TYR . . . 104.73 84.82 1.8 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.26 134.92 7.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.262 -1.14 . . . . 0.0 109.987 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.603 ' CZ3' ' HB2' ' A' ' 2' ' ' TYR . 2.4 m95 -78.96 88.77 4.74 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.607 -0.683 . . . . 0.0 109.608 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 CA-C-O 117.925 -1.486 . . . . 0.0 109.502 -179.897 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.459 ' CZ ' ' HA2' ' A' ' 7' ' ' GLY . 66.2 t80 -78.76 138.6 38.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -1.134 . . . . 0.0 109.486 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -103.54 117.48 59.88 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.255 -0.903 . . . . 0.0 109.142 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -75.97 -9.26 19.37 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.317 2.012 . . . . 0.0 110.424 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -84.36 -49.78 8.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.228 -0.92 . . . . 0.0 109.106 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.2 m -100.04 -48.82 4.51 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.28 -0.888 . . . . 0.0 109.19 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.459 ' HA2' ' CZ ' ' A' ' 2' ' ' TYR . . . 91.68 61.08 1.24 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.63 149.87 46.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.162 -1.199 . . . . 0.0 109.732 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.604 ' CE3' ' HA ' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -100.12 11.35 39.56 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.731 -179.505 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 CA-C-O 118.022 -1.432 . . . . 0.0 109.539 179.989 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -83.24 133.79 34.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -1.122 . . . . 0.0 109.437 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -98.96 116.11 65.43 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.311 -0.868 . . . . 0.0 109.287 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.66 -4.27 14.78 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.257 1.971 . . . . 0.0 110.102 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.432 ' OE1' ' HA ' ' A' ' 5' ' ' GLU . 7.0 tp10 -87.29 -49.37 7.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.332 -0.855 . . . . 0.0 109.092 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.4 p -107.56 -41.36 5.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.34 -0.85 . . . . 0.0 109.236 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.44 79.92 1.48 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.24 149.88 29.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.176 -1.191 . . . . 0.0 109.81 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.616 ' CE3' ' HA ' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -98.62 -25.79 14.6 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.501 -0.75 . . . . 0.0 109.963 -179.479 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 CA-C-O 117.975 -1.458 . . . . 0.0 109.568 180.0 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.532 ' CZ ' ' HA2' ' A' ' 7' ' ' GLY . 63.0 t80 -87.54 153.19 21.6 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.31 -1.112 . . . . 0.0 109.239 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -122.7 117.07 28.95 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.181 -0.95 . . . . 0.0 109.315 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.66 -9.25 17.17 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.282 1.988 . . . . 0.0 110.196 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -76.36 -38.91 55.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.368 -0.832 . . . . 0.0 109.137 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.9 m -117.07 -55.34 2.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.27 -0.894 . . . . 0.0 108.982 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.532 ' HA2' ' CZ ' ' A' ' 2' ' ' TYR . . . 109.9 85.17 1.61 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.1 m -156.8 150.75 24.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -1.155 . . . . 0.0 109.83 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.614 ' CE3' ' HA ' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -101.87 79.66 1.93 Allowed 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.002 -179.563 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.858 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.597 ' HB2' ' CZ3' ' A' ' 9' ' ' TRP . 74.8 t80 -84.83 97.91 10.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -1.134 . . . . 0.0 109.577 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.426 ' OD2' ' HB3' ' A' ' 5' ' ' GLU . 38.5 t70 -71.7 115.19 35.24 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.321 -0.862 . . . . 0.0 109.051 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 34.6 Cg_endo -75.96 -12.83 19.64 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.258 1.972 . . . . 0.0 110.214 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.426 ' HB3' ' OD2' ' A' ' 3' ' ' ASP . 0.7 OUTLIER -60.28 -39.37 86.6 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.263 -0.898 . . . . 0.0 108.904 179.536 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.1 p -107.05 -22.46 12.65 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.377 -0.827 . . . . 0.0 109.002 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.81 34.07 7.98 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.7 165.35 30.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.066 -1.255 . . . . 0.0 109.935 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.597 ' CZ3' ' HB2' ' A' ' 2' ' ' TYR . 4.9 m95 -69.16 107.11 3.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.382 -0.824 . . . . 0.0 109.375 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 CA-C-O 117.98 -1.455 . . . . 0.0 109.612 -179.929 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.607 ' HB2' ' CZ3' ' A' ' 9' ' ' TRP . 90.1 t80 -94.49 110.13 21.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -1.146 . . . . 0.0 109.459 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.456 ' OD1' ' HB2' ' A' ' 5' ' ' GLU . 12.9 t70 -77.8 114.0 37.53 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.161 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 36.1 Cg_endo -78.56 -27.67 4.92 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.291 1.994 . . . . 0.0 110.315 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.456 ' HB2' ' OD1' ' A' ' 3' ' ' ASP . 0.2 OUTLIER -51.49 -43.43 62.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.327 -0.858 . . . . 0.0 109.395 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 44.4 p -99.47 -19.51 16.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -0.925 . . . . 0.0 109.483 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.458 ' O ' ' OH ' ' A' ' 2' ' ' TYR . . . 90.98 24.39 27.46 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.453 ' HA ' ' CE1' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -160.35 172.18 17.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -1.139 . . . . 0.0 109.631 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.607 ' CZ3' ' HB2' ' A' ' 2' ' ' TYR . 5.1 m95 -68.88 107.78 3.21 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.382 -0.824 . . . . 0.0 109.381 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.927 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.594 ' HB2' ' CZ3' ' A' ' 9' ' ' TRP . 85.1 t80 -83.29 109.56 17.35 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.284 -1.127 . . . . 0.0 109.489 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -74.42 114.3 32.39 Favored Pre-proline 0 N--CA 1.488 1.43 0 O-C-N 121.212 -0.93 . . . . 0.0 109.055 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 34.6 Cg_endo -76.23 -29.53 6.29 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.234 1.956 . . . . 0.0 110.229 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -62.18 -35.71 79.68 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.193 -0.942 . . . . 0.0 108.929 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 53.3 m -94.97 -16.7 22.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.267 -0.895 . . . . 0.0 109.144 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.469 ' O ' ' OH ' ' A' ' 2' ' ' TYR . . . 76.79 18.76 78.57 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.406 ' HA ' ' CE1' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -160.77 171.81 18.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.294 -1.121 . . . . 0.0 109.593 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.594 ' CZ3' ' HB2' ' A' ' 2' ' ' TYR . 9.4 m95 -68.79 112.22 5.37 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.348 -0.845 . . . . 0.0 109.533 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 CA-C-O 118.0 -1.445 . . . . 0.0 109.509 -179.98 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.593 ' HB2' ' CZ3' ' A' ' 9' ' ' TRP . 84.6 t80 -88.73 103.28 15.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.237 -1.155 . . . . 0.0 109.762 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -73.67 116.6 53.27 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.217 -0.927 . . . . 0.0 108.689 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -74.23 -27.43 11.6 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.175 1.917 . . . . 0.0 110.321 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.446 ' O ' ' HG3' ' A' ' 5' ' ' GLU . 1.1 tp10 -67.84 -24.2 65.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 108.56 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.19 -18.89 13.99 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.52 -0.737 . . . . 0.0 109.074 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.32 24.61 76.08 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.34 164.51 32.43 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.046 -1.267 . . . . 0.0 109.988 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.593 ' CZ3' ' HB2' ' A' ' 2' ' ' TYR . 6.6 m95 -69.03 -167.59 0.11 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.433 -0.792 . . . . 0.0 109.207 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 CA-C-O 118.02 -1.433 . . . . 0.0 109.629 179.911 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.597 ' HA ' ' CE3' ' A' ' 9' ' ' TRP . 83.2 t80 -73.25 135.69 44.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -1.105 . . . . 0.0 109.259 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -95.81 109.52 46.71 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.335 -0.853 . . . . 0.0 109.279 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 35.4 Cg_endo -77.14 -28.32 5.97 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.33 2.02 . . . . 0.0 110.155 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -51.97 -53.53 40.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.262 -0.899 . . . . 0.0 108.979 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.6 t -99.99 -7.01 25.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.38 -0.825 . . . . 0.0 109.315 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.439 ' C ' ' OH ' ' A' ' 2' ' ' TYR . . . 71.24 33.31 64.82 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.53 156.16 25.39 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.125 -1.221 . . . . 0.0 110.102 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.597 ' CE3' ' HA ' ' A' ' 2' ' ' TYR . 11.0 m95 -68.95 -35.42 76.75 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.565 -0.709 . . . . 0.0 109.759 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 CA-C-O 118.03 -1.428 . . . . 0.0 109.735 -179.77 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.604 ' HB2' ' CZ3' ' A' ' 9' ' ' TRP . 89.8 t80 -71.71 166.84 21.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -1.091 . . . . 0.0 109.524 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.492 ' N ' ' CG ' ' A' ' 2' ' ' TYR . 0.6 OUTLIER -127.15 112.53 21.61 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.317 -0.864 . . . . 0.0 109.01 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.99 -37.48 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.203 1.935 . . . . 0.0 110.73 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -61.65 -47.77 83.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.108 -0.995 . . . . 0.0 108.9 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 57.4 m -80.78 -62.69 1.6 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.359 -0.838 . . . . 0.0 108.934 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.415 ' C ' ' OH ' ' A' ' 2' ' ' TYR . . . 127.2 22.95 1.46 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.432 ' O ' ' HB2' ' A' ' 3' ' ' ASP . 0.6 OUTLIER -160.57 172.24 17.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.043 -1.269 . . . . 0.0 110.02 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.604 ' CZ3' ' HB2' ' A' ' 2' ' ' TYR . 25.0 m95 -68.76 -43.02 76.68 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.487 -0.758 . . . . 0.0 109.602 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 CA-C-O 118.069 -1.406 . . . . 0.0 109.586 -179.94 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.577 ' HB2' ' CZ3' ' A' ' 9' ' ' TRP . 17.5 t80 -115.43 105.88 13.33 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.188 -1.184 . . . . 0.0 109.562 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -77.59 114.45 41.06 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.251 -0.906 . . . . 0.0 109.156 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 34.7 Cg_endo -76.8 -22.9 11.4 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.263 1.976 . . . . 0.0 110.32 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -54.03 -25.46 21.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -0.888 . . . . 0.0 109.148 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.4 p -121.01 -53.23 2.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.368 -0.832 . . . . 0.0 109.266 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.91 62.85 0.52 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.49 147.56 27.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.202 -1.175 . . . . 0.0 109.868 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.588 ' CE3' ' HA ' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -77.31 -18.81 57.19 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.84 -179.369 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 CA-C-O 117.967 -1.463 . . . . 0.0 109.538 -179.926 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.52 ' HB2' ' CH2' ' A' ' 9' ' ' TRP . 72.5 t80 -70.62 117.06 11.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.17 -1.194 . . . . 0.0 109.64 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -81.13 114.54 49.76 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.196 -0.94 . . . . 0.0 109.117 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 35.1 Cg_endo -77.82 -33.99 1.99 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.413 2.075 . . . . 0.0 110.497 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -68.3 -55.05 13.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.194 -0.941 . . . . 0.0 109.402 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.441 HG22 ' OG1' ' A' ' 8' ' ' THR . 55.9 m -80.28 -21.75 42.34 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.322 -0.861 . . . . 0.0 109.166 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 62.93 59.13 9.56 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.441 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -145.47 149.73 35.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.167 -1.196 . . . . 0.0 109.668 179.88 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.602 ' CE3' ' HA ' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -87.59 38.27 0.82 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.545 -0.722 . . . . 0.0 109.907 -179.389 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.354 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.62 -179.912 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.471 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 18.5 t80 -87.78 109.58 19.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.211 -1.17 . . . . 0.0 109.515 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -73.32 114.04 27.78 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.297 -0.877 . . . . 0.0 109.254 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 34.8 Cg_endo -77.55 -26.81 6.8 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.318 2.012 . . . . 0.0 110.55 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -53.43 -56.88 13.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.069 -1.019 . . . . 0.0 109.349 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.0 p -91.5 -38.47 12.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.093 -1.004 . . . . 0.0 109.376 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.56 67.59 1.11 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.58 152.15 33.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -1.124 . . . . 0.0 109.804 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.609 ' CE3' ' HA ' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -83.06 -56.25 3.9 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.59 -0.693 . . . . 0.0 109.892 -179.259 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 CA-C-O 117.987 -1.451 . . . . 0.0 109.566 -179.951 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.465 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 84.5 t80 -65.25 120.0 11.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.239 -1.154 . . . . 0.0 109.58 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.29 114.0 51.97 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.238 -0.914 . . . . 0.0 109.264 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 35.2 Cg_endo -77.45 -12.75 16.9 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.337 2.025 . . . . 0.0 110.418 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.19 -52.76 6.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.253 -0.904 . . . . 0.0 109.386 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 63.9 p -83.8 -46.15 12.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 109.395 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.19 62.38 1.29 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.2 m -158.32 153.97 26.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -1.166 . . . . 0.0 109.718 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.621 ' CE3' ' HA ' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -93.84 89.16 6.02 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.567 -0.708 . . . . 0.0 109.737 -179.545 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.948 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.444 ' HB2' ' CH2' ' A' ' 9' ' ' TRP . 11.5 t80 -72.02 103.55 3.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -1.17 . . . . 0.0 109.65 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.403 ' OD1' ' HD2' ' A' ' 4' ' ' PRO . 45.3 t0 -84.29 117.85 69.72 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.348 -0.845 . . . . 0.0 109.173 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.403 ' HD2' ' OD1' ' A' ' 3' ' ' ASP . 34.3 Cg_endo -76.96 -16.42 16.02 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.273 1.982 . . . . 0.0 110.227 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.04 -16.31 62.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 108.926 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.5 m -116.47 -54.27 2.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.458 -0.776 . . . . 0.0 109.267 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.63 53.0 1.08 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.25 152.83 22.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.215 -1.167 . . . . 0.0 109.861 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.597 ' CE3' ' HA ' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -84.72 -72.89 0.45 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.604 -0.685 . . . . 0.0 109.759 -179.462 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 CA-C-O 117.984 -1.453 . . . . 0.0 109.533 179.903 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.53 ' HB2' ' CH2' ' A' ' 9' ' ' TRP . 60.2 t80 -87.13 127.18 35.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -1.152 . . . . 0.0 109.554 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -89.34 113.96 58.5 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.241 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 35.3 Cg_endo -77.54 -9.88 17.3 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.322 2.014 . . . . 0.0 110.41 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -81.26 -57.31 3.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 109.355 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.6 m -85.44 -45.24 12.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.285 -0.884 . . . . 0.0 109.468 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.98 71.55 1.07 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.5 m -154.12 152.4 30.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -1.148 . . . . 0.0 109.794 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.617 ' CE3' ' HA ' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -93.27 57.7 2.72 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.824 -179.472 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 9' ' ' TRP . . . . . . . . 0 N--CA 1.49 2.263 0 CA-C-O 118.036 -1.424 . . . . 0.0 109.596 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.537 ' HB2' ' CH2' ' A' ' 9' ' ' TRP . 32.5 t80 -106.27 111.2 23.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -1.139 . . . . 0.0 109.537 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -94.38 118.45 67.01 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.296 -0.877 . . . . 0.0 109.276 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.06 -23.08 9.46 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.293 1.996 . . . . 0.0 110.337 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -53.31 -20.97 4.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 109.461 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -128.99 -47.28 1.23 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.286 -0.884 . . . . 0.0 109.267 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.86 64.97 0.82 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.94 150.77 33.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.108 -1.23 . . . . 0.0 109.858 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.618 ' CE3' ' HA ' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -90.88 42.8 1.12 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.563 -0.711 . . . . 0.0 109.927 -179.29 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 CA-C-O 117.955 -1.469 . . . . 0.0 109.552 179.945 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.603 ' HB2' ' CZ3' ' A' ' 9' ' ' TRP . 32.2 t80 -99.75 119.04 37.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -1.155 . . . . 0.0 109.48 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.74 117.83 67.72 Favored Pre-proline 0 N--CA 1.487 1.425 0 O-C-N 121.218 -0.926 . . . . 0.0 109.334 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -76.6 -22.18 12.33 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.363 2.042 . . . . 0.0 110.253 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -66.61 -43.86 83.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.349 -0.845 . . . . 0.0 109.112 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.7 m -102.47 -58.06 1.94 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.332 -0.855 . . . . 0.0 109.221 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.0 80.04 0.82 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.86 149.29 27.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -1.175 . . . . 0.0 109.86 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.603 ' CZ3' ' HB2' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -88.57 8.55 27.71 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.708 -0.62 . . . . 0.0 109.94 -179.395 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 CA-C-O 117.952 -1.471 . . . . 0.0 109.572 -179.978 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.603 ' HB2' ' CZ3' ' A' ' 9' ' ' TRP . 61.5 t80 -93.52 110.12 21.71 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.221 -1.164 . . . . 0.0 109.486 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -73.39 115.04 37.21 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.208 -0.932 . . . . 0.0 109.032 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 34.4 Cg_endo -75.71 -10.23 20.02 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.225 1.95 . . . . 0.0 110.163 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -81.02 -40.58 24.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.296 -0.877 . . . . 0.0 108.751 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.4 m -111.81 -52.58 2.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.395 -0.815 . . . . 0.0 108.827 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.468 ' HA2' ' CZ ' ' A' ' 2' ' ' TYR . . . 104.73 84.82 1.8 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.26 134.92 7.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.262 -1.14 . . . . 0.0 109.987 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.603 ' CZ3' ' HB2' ' A' ' 2' ' ' TYR . 2.4 m95 -78.96 88.77 4.74 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.607 -0.683 . . . . 0.0 109.608 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 CA-C-O 117.925 -1.486 . . . . 0.0 109.502 -179.897 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.459 ' CZ ' ' HA2' ' A' ' 7' ' ' GLY . 66.2 t80 -78.76 138.6 38.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -1.134 . . . . 0.0 109.486 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -103.54 117.48 59.88 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.255 -0.903 . . . . 0.0 109.142 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -75.97 -9.26 19.37 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.317 2.012 . . . . 0.0 110.424 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -84.36 -49.78 8.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.228 -0.92 . . . . 0.0 109.106 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.2 m -100.04 -48.82 4.51 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.28 -0.888 . . . . 0.0 109.19 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.459 ' HA2' ' CZ ' ' A' ' 2' ' ' TYR . . . 91.68 61.08 1.24 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.63 149.87 46.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.162 -1.199 . . . . 0.0 109.732 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.604 ' CE3' ' HA ' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -100.12 11.35 39.56 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.731 -179.505 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 CA-C-O 118.022 -1.432 . . . . 0.0 109.539 179.989 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -83.24 133.79 34.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -1.122 . . . . 0.0 109.437 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -98.96 116.11 65.43 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.311 -0.868 . . . . 0.0 109.287 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.66 -4.27 14.78 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.257 1.971 . . . . 0.0 110.102 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.432 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 7.0 tp10 -87.29 -49.37 7.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.332 -0.855 . . . . 0.0 109.092 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.4 p -107.56 -41.36 5.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.34 -0.85 . . . . 0.0 109.236 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.44 79.92 1.48 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.24 149.88 29.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.176 -1.191 . . . . 0.0 109.81 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.616 ' CE3' ' HA ' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -98.62 -25.79 14.6 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.501 -0.75 . . . . 0.0 109.963 -179.479 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 CA-C-O 117.975 -1.458 . . . . 0.0 109.568 180.0 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.532 ' CZ ' ' HA2' ' A' ' 7' ' ' GLY . 63.0 t80 -87.54 153.19 21.6 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.31 -1.112 . . . . 0.0 109.239 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -122.7 117.07 28.95 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.181 -0.95 . . . . 0.0 109.315 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.66 -9.25 17.17 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.282 1.988 . . . . 0.0 110.196 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -76.36 -38.91 55.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.368 -0.832 . . . . 0.0 109.137 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.9 m -117.07 -55.34 2.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.27 -0.894 . . . . 0.0 108.982 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.532 ' HA2' ' CZ ' ' A' ' 2' ' ' TYR . . . 109.9 85.17 1.61 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.1 m -156.8 150.75 24.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -1.155 . . . . 0.0 109.83 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.614 ' CE3' ' HA ' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -101.87 79.66 1.93 Allowed 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.002 -179.563 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.858 . . . . . . . . 0 0 . 1 stop_ save_